S

Spruce Biosciences Inc
D

SPRB

64.950
USD
2.83
(4.56%)
مفتوح الان
حجم التداول
2,702
الربح لكل سهم
-45
العائد الربحي
-
P/E
-1
حجم السوق
69,145,902
المقالات

العنوان: Spruce Biosciences Inc

القطاع: Healthcare
الصناعة: Biotechnology
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The pipeline products of the company include Tralesinidase Alfa (TA-ERT), and Tildacerfont/ Cortibon, a Companion Diagnostic, developed in partnership with HMNC Brain Health.